Skip to main content

Author: Leigh MacMillan

New target for chronic kidney disease

Jan. 31, 2019—Preventing the formation of secretory structures that promote scarring in the kidney could offer new therapeutic options for a disease that affects millions of people worldwide.

Read more


Cell death pathway implicated in bone marrow failure

Jan. 31, 2019—Vanderbilt investigators have linked a specific form of programmed cell death to myelodysplastic syndrome, a type of bone marrow failure.

Read more


Radiologist Taber thrives on teaching, diagnostic challenges

Jan. 24, 2019—David Taber, MD, has practiced radiology for more than 40 years, with the first half of his career spent in private practice and the second half at Vanderbilt University Medical Center. In addition to his clinical practice within the musculoskeletal and emergency radiology section of the Department of Radiology, Taber serves as an assistant director of the diagnostic radiology residency program.

Read more


Pain relievers a risk for C. diff?

Jan. 17, 2019—A link between anti-inflammatory drugs such as ibuprofen and C. diff infection suggests caution against overusing such drugs in patients at high risk for infection.

Read more


Public health expert Galea set for Discovery Lecture

Jan. 17, 2019—Sandro Galea, MD, MPH, DrPH, Dean and Robert A. Knox Professor at Boston University School of Public Health, will deliver the next Flexner Discovery Lecture on Thursday, Jan. 24.

Read more


Building a pancreas

Jan. 17, 2019—Vanderbilt investigators are defining the genetic programs that control the development of pancreatic beta cells — studies that could inform new cellular or regenerative therapies for diabetes.

Read more


Bile acids mediate metabolic benefits of weight-loss surgery

Jan. 10, 2019—A team of Vanderbilt investigators has pinpointed the role of bile acids and a specific signaling pathway in the positive metabolic effects of weight-loss surgery.

Read more


UT Southwestern’s Hobbs to discuss genetics of fatty liver disease

Jan. 7, 2019—Helen Hobbs, MD, internationally renowned for her work defining the genetic determinants of plasma lipid levels and cardiovascular risk, will kick off the 2019 Flexner Discovery Lecture series Thursday, Jan. 10.

Read more


Breast cancer-killing RIG

Dec. 13, 2018—A compound that activates a virus-sensing receptor has potent therapeutic effects in a mouse model of breast cancer.

Read more


RNA processing and antiviral immunity

Dec. 13, 2018—John Karijolich and colleagues have discovered a link between cellular RNA processing and the innate cellular immune response to viral pathogens.

Read more


Team seeks to create gene expression map of worm’s nervous system

Dec. 6, 2018—How do you build a brain? What “rules” govern where neurons end up, how they connect to each other, and which functions they perform?

Read more


Vanderbilt Prize winner shares career insights

Dec. 6, 2018—Lynne Maquat, PhD, recipient of the 2017 Vanderbilt Prize in Biomedical Science, shared some career advice with graduate students and postdoctoral fellows at her Vanderbilt Prize lecture last week.

Read more


Recent Stories from VUMC News and Communications Publications

Betsy Williams has firsthand advice for parents on the fence about whether their adolescent children should be vaccinated for the common human papilloma virus (HPV), which can lead to six types of cancer.  Don’t hesitate. Do it.

Momentum

Betsy Williams has firsthand advice for parents on the fence about whether their adolescent children should be vaccinated for the common human papilloma virus (HPV), which can lead to six types of cancer. Don’t hesitate. Do it.

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

Vanderbilt Medicine

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

VUMC campus

VUMC campus

Vanderbilt University School of Medicine entrance

Vanderbilt University School of Medicine entrance

more